• Publications
  • Influence
Cannabis as a substitute for prescription drugs – a cross-sectional study
Patient-reported outcomes support prior research that individuals are using cannabis as a substitute for prescription drugs, particularly, narcotics/opioids, and independent of whether they identify themselves as medical or non-medical users. Expand
Regulatory Status of Cannabidiol in the United States: A Perspective
Recent FDA approval of Epidiolex (CBD) as a treatment for certain pediatric seizure disorders will prompt scheduling of CBD and likely alter FDA enforcement of the Federal Food, Drug, and Cosmetic Act (FD&C), which to date has mostly been in the form of warning letters. Expand
A Cross-Sectional Study of Cannabidiol Users
Consumers are using CBD as a specific therapy for multiple diverse medical conditions—particularly pain, anxiety, depression, and sleep disorders, and these data provide a compelling rationale for further research to better understand the therapeutic potential of CBD. Expand
Indications and administration practices amongst medical cannabis healthcare providers: a cross-sectional survey
Individuals who recommend the medical use of cannabis appear to be self-generating a community standard of practice in the absence of formal clinical guidelines on dosing, interactions and other characteristics. Expand
Labeling of Cannabidiol Products: A Public Health Perspective.
Accurate and informative labeling of hemp and hemp-derived CBD products is an important public health issue and a better understanding of the basic framework for FDA labeling and marketing regulations for food, dietary supplements and drugs is warranted. Expand
Randomized controlled trials investigating the relationship between dietary pattern and high-sensitivity C-reactive protein: a systematic review
The efficacy of dietary patterns for the treatment of elevated hsCRP as a strategy for primary prevention of CHD may be best elucidated in randomized clinical trials in healthy participants with elevated h sCRP but low or normal traditional risk factors, or by using more aggressive dietary modifications in high-risk patients. Expand
The Endocannabinoid System and its Modulation by Cannabidiol (CBD).
Modulating the activity of this system may offer tremendous therapeutic promise for a diverse scope of diseases, ranging from mental health disorders, neurological and movement disorders, pain, autoimmune disease, spinal cord injury, cancer, cardiometabolic disease, stroke, TBI, osteoporosis, and others. Expand
Prospective Safety Evaluation of a Cardiovascular Health Dietary Supplement in Adults with Prehypertension and Stage I Hypertension
The findings of this study suggest that the investigated dietary supplement is safe for long-term use in adults with prehypertension and stage I hypertension, and the increase in serum potassium and decreases in systolic and diastolic blood pressure are promising. Expand
Cannabinol and Sleep: Separating Fact from Fiction.
  • Jamie Corroon
  • Medicine
  • Cannabis and cannabinoid research
  • 31 August 2021
In recent years, marketers of cannabis (i.e., marijuana) products have claimed that cannabinol (CBN) has unique sleep-promoting effects. Despite a plausible mechanism, it is possible that such claimsExpand
Effects of a topical botanically-enriched salve on cutaneous oxygenation.
Findings support consideration of topical treatments containing botanical ingredients to increase cutaneous oxygen delivery in the lower extremity in patients with type 2 diabetes. Expand